![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Inflammatory Bowel Diseases |
Free Subscription
4 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Association of golimumab trough concentrations during maintenance with clinical,
biological, endoscopic and histologic remission in patients with ulcerative
colitis.
Aliment Pharmacol Ther. 2022 May 4. doi: 10.1111/apt.16964.
PubMed
Abstract available
Systematic review-Pancreatic involvement in inflammatory bowel disease.
Aliment Pharmacol Ther. 2022 May 3. doi: 10.1111/apt.16949.
PubMed
Abstract available
Editorial: choosing the optimal screening method for latent TB in patients with
IBD commencing anti-TNF-therapy-authors' reply.
Aliment Pharmacol Ther. 2022;55:1348-1349.
PubMed
Editorial: choosing the optimal screening method for latent TB in patients with
IBD commencing anti-TNF therapy.
Aliment Pharmacol Ther. 2022;55:1346-1347.
PubMed
Exclusive enteral nutrition remodels the intestinal flora in patients with active
Crohn's disease.
BMC Gastroenterol. 2022;22:212.
PubMed
Abstract available
A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with
Inflammatory Bowel Disease.
Dig Dis Sci. 2022 May 5. pii: 10.1007/s10620-022-07507.
PubMed
Abstract available
Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients
with Inflammatory Bowel Disease: A Nationally Representative Cohort Study.
Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07505.
PubMed
Abstract available
Real-World Guidance from Artificial Intelligence? Predicting Outcomes of
Inflammatory Bowel Disease Using Machine Learning.
Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07511.
PubMed
Development of an Inflammatory Bowel Disease-Specific Medication Adherence
Instrument and Reasons for Non-adherence.
Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07517.
PubMed
Abstract available
A Novel Decision Aid Improves Quality of Reproductive Decision-Making and
Pregnancy Knowledge for Women with Inflammatory Bowel Disease.
Dig Dis Sci. 2022 Apr 30. pii: 10.1007/s10620-022-07494.
PubMed
Abstract available
Expert Commentary on Chronic Perineal Sinus After Proctectomy for Crohn's
Disease: Risk Reduction Strategies and Management.
Dis Colon Rectum. 2022;65:472.
PubMed
Chronic Perineal Sinus After Proctectomy for Crohn's Disease: Risk Reduction
Strategies and Management.
Dis Colon Rectum. 2022;65:468-471.
PubMed
When neurology meets gastroenterology: an unusual case of ulcerative colitis.
Gastroenterology. 2022 Apr 27. pii: S0016-5085(22)00447.
PubMed
Over-expression of Programmed Death Ligand 1 (PD-L1) in Refractory Inflammatory
Bowel Disease (IBD).
Hum Pathol. 2022 Apr 27. pii: S0046-8177(22)00101.
PubMed
Abstract available
Wernicke Encephalopathy in Ulcerative Colitis.
Inflamm Bowel Dis. 2022;28:e70-e71.
PubMed
Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect
of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in
Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2022;28:e61.
PubMed
Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor
Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug
Concentrations in Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2022;28:e59-e60.
PubMed
Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2
Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative
Colitis.
Inflamm Bowel Dis. 2022 Apr 30. pii: 6576383. doi: 10.1093.
PubMed
Association between inflammatory bowel disease and spondyloarthritis: findings
from a nationwide study in Sweden.
J Crohns Colitis. 2022 May 5. pii: 6581445. doi: 10.1093.
PubMed
Abstract available
A narrative systematic review and categorisation of outcomes in Inflammatory
Bowel Disease to inform a Core Outcome Set for real-world evidence.
J Crohns Colitis. 2022 May 5. pii: 6580715. doi: 10.1093.
PubMed
Abstract available
Comparative risk of incident cancer in patients with Inflammatory Bowel Disease
with prior non-digestive malignancy according to immunomodulator: a multicenter
cohort study.
J Crohns Colitis. 2022 May 5. pii: 6580681. doi: 10.1093.
PubMed
Abstract available
Predictors of each quality of life dimension in Crohn's disease patients
initiating an anti-TNF treatment: differentiated effects of patient-, disease-,
and treatment-related characteristics.
Scand J Gastroenterol. 2022;57:566-573.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by